Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework.
Katsura TsukamotoMiriam CnopDaichi MoriShoen KumeTakayuki AnazawaMasako DoiKazuhiko ChikazawaNaoki MatsumaruPublished in: Therapeutic innovation & regulatory science (2018)
Antidiabetic drug development in Japan costs less than that in the other regions, although novel development is less active because of regulatory differences. To achieve better pharmacotherapy for diabetes, the regulatory framework requires careful consideration.